세계의 풍선판막성형술 디바이스 시장 : 제품 유형별, 용도별, 연령층별, 최종 용도별 - 예측(2024-2032년)

Global Balloon Valvuloplasty Devices Market size is predicted to record 4.8% CAGR from 2024 to 2032, due to the rising healthcare expenditure and advancements in healthcare infrastructure. According to the American Medical Association, the healthcare spending in the U.S. increased by 4.1% in 2022 to $4.5 trillion or $13,493 per capita. This rise is supporting greater investment in advanced treatments for improved cardiac care.

Of late, significant resources are being allocated towards innovative treatments, including balloon valvuloplasty on account of the increasing healthcare expenditure. The expansion and enhancement of healthcare facilities are improving access to advanced procedures. In addition, the increasing investments in healthcare infrastructure is supporting the widespread use of balloon valvuloplasty devices, making them more accessible and effective in treating heart valve conditions.

The balloon valvuloplasty devices market is segregated into product type, application, age group, end-use, and region.

By product type, the cutting balloons segment is estimated to grow at a significant rate from 2024 to 2032, due to increasing demand to treat narrowed heart valves. These devices are making significant strides in improving cardiac care by offering a less invasive option compared to traditional surgical methods. Moreover, cutting balloons equipped with sharp blades have a prominent role in treating stenosis by making precise incisions in the valve's tissue which helps in widening the valve and restoring normal blood flow.

Balloon valvuloplasty devices industry from the ambulatory surgical centers end-use segment is expected to rise from 2024 to 2032, fueled by the increasing need for providing specialized care for patients with heart conditions. Balloon valvuloplasty devices are used in these centers to treat patients with narrowed heart valves. This technique allows minimally invasive procedures for improving patient outcomes and recovery times. By integrating these devices into their services, ambulatory surgical centers are ensuring that they are at the forefront of cardiac care for offering patients safer and more effective treatment options.

Regionally, the Europe balloon valvuloplasty devices industry size is anticipated to depict robust growth between 2024 and 2032, propelled by the aging population and the expansion of cardiovascular procedures. Healthcare providers in the region are adopting these devices to manage heart valve conditions more effectively. Subsequently, the rapid advancements in medical technology and the higher volume of procedures to address the complexities of the aging population with enhanced precision and care will drive the product uptake across Europe.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of valvular heart disease
    • 3.2.1.2 Rising geriatric population
    • 3.2.1.3 Growing technological advancements
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Limitations of balloon valvuloplasty
    • 3.2.2.2 Risk of complications
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Standard balloon
• 5.3 Cutting balloon
• 5.4 Scoring balloon
• 5.5 High-pressure balloon
• 5.6 Low-pressure balloon

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Aortic valve stenosis
• 6.3 Pulmonary valve stenosis

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pediatric
• 7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centres
• 8.4 Specialty clinics
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 B. Braun Melsungen AG
• 10.3 Becton, Dickinson, and Company
• 10.4 Boston Scientific Corporation
• 10.5 Cardinal Health, Inc.
• 10.6 Cook Medical Inc.
• 10.7 Edwards Lifesciences Corporation
• 10.8 Innomed Medical Development Ltd.
• 10.9 Jotech GmbH
• 10.10 Medtronic plc
• 10.11 Microport Scientific Corporation
• 10.12 Numed Canada Inc.
• 10.13 NuMED Inc.
• 10.14 Osypka Medical GmbH
• 10.15 Teleflex Incorporated